LEADER 04875nam  2200553Ia 450 
001 9910825101103321
005 20200520144314.0
010   $a1-61705-130-6
035   $a(CKB)2670000000387536
035   $a(EBL)1218689
035   $a(OCoLC)851972265
035   $a(SSID)ssj0000916144
035   $a(PQKBManifestationID)12402809
035   $a(PQKBTitleCode)TC0000916144
035   $a(PQKBWorkID)10874728
035   $a(PQKB)10962089
035   $a(MiAaPQ)EBC1218689
035   $a(EXLCZ)992670000000387536
100   $a20130220d2013      uy         0
101 0 $aeng
135   $aur|n|---uuuuu
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aOncology boards flash review /$fFrancis P. Worden, Rami N. Khoriaty, editors ; Binu Malhotra, Brian Parkin, associate editors
210   $aNew York $cDemos Medical Pub.$dc2013
215   $a1 online resource
300   $aIncludes index.
311   $a1-936287-81-1 
327   $aCover; Title; Copyright; Contents; Contributors; Preface; Part I: Hematologic Malignancies; Chapter 1: Acute Myeloid Leukemia; Epidemiology; Etiology and Risk Factors; Classification; Signs and Symptoms; Diagnostic Criteria; Indications for Treatment; Prognostic Factors; Treatment; Acute Lymphoblastic Leukemia (ALL); Hairy Cell Leukemia (HCL); Chapter 2: Chronic Lymphocytic Leukemia; Epidemiology; Etiology and Risk Factors; Staging; Signs and Symptoms; Diagnostic Criteria; Indications for Treatment; Prognostic Factors; Treatment; Special Considerations
327   $aChapter 3: Chronic Myeloid Leukemia and Myeloproliferative NeoplasmsChronic Myelogenous Leukemia (CML); Myeloproliferative Neoplasms (General); Polycythemia Vera (PV); Essential Thrombocythemia (ET); Primary Myelofibrosis (PMF); Chapter 4: Myelodysplastic Syndromes; Epidemiology; Etiology and Risk Factors; Classification; Signs and Symptoms; Diagnostic Criteria; Prognostic Factors; Indications for Treatment; Treatment; Chapter 5: Hodgkin's Lymphoma; Epidemiology; Etiology and Risk Factors; Staging; Signs and Symptoms; Diagnostic Criteria; Indications for Treatment; Prognostic Factors
327   $aTreatmentSpecial Considerations; Chapter 6: Non-Hodgkin's Lymphoma-Low Grade; Epidemiology; Etiology and Risk Factors; Staging; Signs and Symptoms; Follicular Lymphoma; Marginal Zone Lymphoma; Lymphoplasmacytic Lymphoma/Waldenstro?m's Macroglobulinemia; Small Lymphocytic Lymphoma (See Chapter 2); Chapter 7: Non-Hodgkin's Lymphoma-High Grade; Diffuse Large B-Cell Lymphoma (DLBCL); Burkitt's Lymphoma (BL); Mantle Cell Lymphoma (MCL); Lymphomas in HIV/AIDS Patients; Chapter 8: Peripheral T-Cell Lymphomas; Epidemiology; Etiology and Risk Factors; Staging; Signs and Symptoms; Diagnostic Criteria
327   $aIndications for TreatmentPrognostic Factors; Treatment; Special Considerations; Chapter 9: Multiple Myeloma and Plasma Cell Dyscrasias; Epidemiology; Etiology and Risk Factors; Staging; Signs and Symptoms; Diagnostic Criteria; Indications for Treatment; Prognostic Factors; Treatment; Special Considerations; Part II: Aerodigestive Malignancies; Chapter 10: Non-Small Cell Lung Cancer; Epidemiology; Etiology and Risk Factors; Screening; Prevention; Pathology; Signs and Symptoms; Diagnostic Workup; Staging; General Treatment Principles; Treatment by Stage; Chapter 11: Small Cell Lung Cancer
327   $aEpidemiologyEtiology and Risk Factors; Staging; Signs and Symptoms; Diagnosis; Prognostic Factors; Treatment; Chapter 12: Malignant Pleural Mesothelioma; Epidemiology; Etiology and Risk Factors; Staging and Histological Classification; Signs and Symptoms; Diagnosis; Prognostic Factors; Treatment; Special Considerations; Chapter 13: Thymoma and Thymic Carcinoma; Epidemiology; Etiology and Risk Factors; Staging and Histological Classification; Signs and Symptoms; Diagnosis; Prognostic and Risk Factors; Treatment; Special Considerations
327   $aChapter 14: Head and Neck Cancers and Salivary Gland Tumors
330   $aCoverage extends across the range of major hematologic malignancies and solid tumors, as well as reviews of pharmacology, biostatistics, genetics and tumor biology, and survivorship and palliative care. Each topic is consistently presented with the key points summarized in bullet point form for easy recall. Question-based headings enable the reader to systematically review and assess his knowledge.
606   $aOncology$xExaminations$vStudy guides
606   $aCancer$xExaminations$vStudy guides
615  0$aOncology$xExaminations
615  0$aCancer$xExaminations
676   $a616.99/40076
701   $aWorden$b Francis P$01044247
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910825101103321
996   $aOncology boards flash review$93959478
997   $aUNINA